Trial Details
RECRUITINGBasic Information
| Clinical ID | c328 |
|---|---|
| Identifier | NCT06764706 |
| Trial Title | Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Severe Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | - |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | Baden-Wurttemberg |
| Country/Region | Germany |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2025-02-27 |
|---|---|
| Primary Completion Date | 2028-07 |
| Completion Date | 2028-07 |